Etika Biomedis

01The Four Principles of Biomedical Ethics

The foundational ethical framework used across almost all clinical ethics questions is the principlist model proposed by Tom Beauchamp and James Childress in 1979. These four principles are not ranked in a fixed hierarchy; instead, they are prima facie obligations, meaning each carries equal weight until they conflict in a given clinical scenario, at which point one must be prioritized based on context.

Autonomy refers to the patient's right to make informed, voluntary decisions about their own medical care. This principle is the direct source of informed consent, informed refusal, and truth-telling. A competent adult patient has the right to refuse any treatment, even if that refusal will result in death. The key requirement is that the patient's decision is made voluntarily, with adequate information, and with decision-making capacity. Questions testing autonomy typically involve a patient refusing a life-saving intervention, or a family member attempting to override a competent patient's wishes.

Beneficence is the obligation to act in the patient's best interest and to actively promote their welfare. This goes beyond simply avoiding harm; it requires the physician to take positive steps toward benefit. In exam vignettes, beneficence appears when a physician must weigh aggressive treatment options against the patient's quality of life, or when deciding whether to intervene paternalistically for a patient who cannot appreciate the benefit of a proposed therapy.

Non-maleficence is the duty to avoid causing harm. Rooted in the Hippocratic tradition of primum non nocere ("first, do no harm"), this principle sets the minimum standard of medical conduct. Even when you cannot help, you must at least not worsen the patient's condition. Exam writers test this through medication side effects, unnecessary procedures, and the concept of proportionality where the expected benefit must outweigh the potential harm.

Justice concerns the fair and equitable distribution of healthcare resources. It asks the question: who receives care when resources are limited? The most commonly tested application is distributive justice, such as organ transplant allocation, triage in disaster settings, and determining who receives a scarce treatment. Justice also covers non-discrimination in care delivery, which is echoed in KODEKI's requirement that physicians serve patients without discrimination.

02Informed Consent and Informed Refusal

Informed consent is not merely a signature on a form. It is a communication process between the physician and the patient. Informed consent is a communication process between medical personnel and patients that includes information about diagnosis, objectives of medical procedures, treatment processes, benefits, risks, and alternative treatments. Indonesian regulations also govern presumed consent under Law No. 17 of 2023, specifically Articles 80 and 293, which allow immediate action in life-threatening conditions.

There are five elements that must all be present for consent to be valid:

Decision-making capacity is assessed clinically and requires the patient to demonstrate four abilities: the ability to communicate a consistent choice, the ability to understand relevant information, the ability to appreciate how the information applies to their own situation, and the ability to reason about treatment options and their consequences. Note that capacity is decision-specific and can fluctuate over time. A patient may have capacity to consent to a blood draw but lack capacity for a complex surgical decision.

Special situations in informed consent:

Minors: In Indonesian law, patients under 18 years of age require consent from a parent or legal guardian. However, in emergency settings, treatment may proceed without parental consent if delay would endanger the child's life.

Emergency exception (presumed consent): When a patient is unconscious, in a life-threatening condition, and no legal guardian is available, the physician may proceed with treatment under the principle of presumed consent. The physician must document the clinical rationale and inform the patient or family as soon as possible afterward.

Therapeutic privilege: This is a limited and controversial exception where the physician withholds certain information because disclosure itself would cause serious harm to the patient (e.g., precipitate a psychiatric crisis). This exception is narrowly applied and is never a blanket justification for withholding bad news.

Informed refusal is the flip side of informed consent. A competent adult patient has the absolute right to refuse any treatment, including life-sustaining therapy. The physician's obligation is to ensure the patient understands the consequences of refusal, document the refusal, and continue to offer alternative care. A patient who refuses blood transfusion on religious grounds, for example, retains that right as long as they are competent and informed.

03Medical Confidentiality

Medical secrets bind the doctor-patient relationship based on various regulations. The Indonesian Doctor's Oath item 4 states that the doctor will keep confidential everything known because of the profession. The 2012 KODEKI in Article 16 states that every doctor is obliged to keep everything known about a patient secret, even after the patient has died. Under Law No. 29 of 2004 on Medical Practice, Article 48 paragraph 1, every doctor or dentist practicing medicine is obliged to keep medical secrets.

Medical secrets may only be disclosed with patient consent, in the interest of the patient's health, for legal proceedings, or as specified by laws and regulations. The core principles are patient consent, data anonymization, and restricting information only to those with authorized need to know.

Permenkes No. 36 of 2012 provides the formal legal framework on medical confidentiality in Indonesia. The scope of medical secrets includes all data and information about a patient's health obtained by healthcare professionals in the course of their duties: identity, history, examination results, diagnosis, treatment plans, and any other information relating to the patient.

The confidentiality obligation persists after the patient's death.

Exceptions to Medical Confidentiality

The exam frequently tests when it is permissible (or mandatory) to break confidentiality. Disclosure of medical secrets based on statutory provisions may be carried out without patient consent in the interest of enforcement of ethics or discipline, as well as in the public interest. Disclosure for disciplinary purposes is provided upon written request from the Professional Ethics Honor Council (MKEK) or the Indonesian Medical Disciplinary Board (MKDKI).

A common exam scenario involves a physician who learns that a patient has a communicable disease and the patient refuses to inform a sexual partner. The correct approach involves counseling the patient first, then, if the patient still refuses, weighing the duty of confidentiality against the obligation to prevent harm to an identifiable third party. Ministry of Health Regulation No. 36 of 2012 regulates medical secrets, which in certain situations can be disclosed but only within defined limits.

04KODEKI and Professional Ethics in Indonesia

KODEKI was first published in 1969 through the National Ethics Working Conference (Mukernas) of IDI, and has been refined through subsequent Mukernas and Konas sessions. In Indonesia, the medical code of ethics is known as KODEKI, drafted by the MKEK and ratified by IDI. KODEKI regulates physician behavior toward patients, colleagues, the public, and themselves to maintain the honor and trust placed in the medical profession.

Starting in 2024, KKI has confirmed that medical ethics questions are included in the competency examination, both in the written test and in the clinical examination.

KODEKI organizes physician obligations into four domains:

Enforcement of KODEKI is carried out by the MKEK, which operates at three levels: branch (MKEK cabang), regional (MKEW), and national (MKEK pusat). Sanctions range from written reprimand and suspension of IDI rank advancement to a recommendation for revocation of the physician's registration certificate (STR) to KKI. The MKEK's decision can serve as grounds for revoking membership in the professional organization, which may result in the loss of the license to practice as a medical doctor in Indonesia.

It is important to distinguish between ethics violations and disciplinary violations:

A single act can simultaneously constitute an ethics violation, a disciplinary violation, and a legal violation. KODEKI addresses both pure ethics violations (without legal implications) and ethics violations that carry legal consequences.

05End-of-Life Ethics

End-of-life ethics questions on the exam typically revolve around three interrelated but distinct concepts: euthanasia, palliative care, and withdrawal of futile treatment.

Euthanasia in Indonesia

The Criminal Code regulates crimes against life in Articles 338 through 350, including murder, assisting suicide, and abortion. The new Criminal Code (Law No. 1 of 2023) does not directly regulate euthanasia, but Article 428 paragraph 1 addresses passive euthanasia with a penalty of up to 2.5 years imprisonment or a fine, and Article 461 addresses active euthanasia at the request of the victim with a penalty of up to nine years imprisonment.

Palliative Care vs. Euthanasia

Indonesian health law recognizes palliative care and permits clinically appropriate end-of-life decisions, including withholding or withdrawing medically futile treatment, where the purpose is to avoid disproportionate intervention and relieve suffering rather than to cause death.

The distinguishing factor is intent. In palliative care, the intent is to relieve suffering, and death may be a foreseeable but unintended consequence (the principle of double effect). In euthanasia, the intent is to cause death. This distinction is heavily tested.

A common exam trap: a physician discontinues ventilator support in a brain-dead patient after family discussion. This is not euthanasia. This is the withdrawal of futile treatment, which is ethically and legally permissible. The question tests whether you can distinguish intent and causation.

06Abortion Ethics and Law in Indonesia

In Indonesian regulation, abortion is illegal, with exceptions for only two reasons: where doctors can prove that there are indications of a medical emergency meaning that abortion is inevitably needed to save the mother's life, which must be accompanied by the woman's husband's or family's permission; or pregnancy due to rape that results in psychological trauma to the woman.

Indonesian laws define abortion as the termination of pregnancy before the fetus is viable, i.e., before 20 weeks of gestation or when the fetus weighs less than 500 grams.

The enactment of Law No. 1 of 2023 concerning the Criminal Code changed previous regulations regarding the timing of when abortion is allowed. Penalties for unlawful abortion can reach up to 10 years imprisonment and a fine of IDR 1 billion, applicable to both the provider and the woman who obtained it.

The ethical tension tested on the exam centers on autonomy vs. legal obligation: a patient may request an abortion for socioeconomic reasons, but the physician is legally prohibited from performing it outside the two exceptions. The correct answer always prioritizes compliance with the law while offering supportive counseling and referral for alternatives.

07Research Ethics

Indonesian regulation of biomedical research ethics draws from several international frameworks:

Indonesian regulation of ethics in biomedical research is based on the Nuremberg Code (1947), which emphasizes protection of the integrity of research participants and their voluntary consent; the Universal Declaration of Human Rights (1948); the Declaration of Helsinki (1964); and operational guidelines for ethics committees.

Key principles tested in research ethics:

Voluntary informed consent in research requires even more rigorous standards than clinical informed consent. Participants must understand that they are in a research study, that participation is voluntary, and that they may withdraw at any time without penalty or loss of standard care.

Equipoise is the ethical basis for randomized controlled trials. A trial is ethically justified only when there is genuine uncertainty (clinical equipoise) within the expert medical community about which treatment arm is superior.

Ethics committee review (Komisi Etik Penelitian) is mandatory for all biomedical research involving human subjects in Indonesia. No research may begin without written approval from an accredited ethics committee.

Vulnerable populations (children, pregnant women, prisoners, cognitively impaired persons, economically or educationally disadvantaged individuals) require additional protections, including the justification that the research cannot be conducted with non-vulnerable subjects and that the expected benefit justifies the risk.

08Physician-Patient Relationship Models

Understanding the models of the physician-patient relationship helps you identify the ethical framework being tested in a vignette:

The modern standard of care favors shared decision-making, which blends elements of the interpretive and deliberative models. The physician brings clinical expertise; the patient brings personal values and preferences.

09Differential Concepts and Distractors

10Traps and High-Yield Pearls

The most common way students fail ethics questions is by defaulting to the physician's perspective instead of identifying which ethical principle the question is actually testing. When a vignette describes a competent patient who refuses a clearly beneficial treatment, many students instinctively choose "give the treatment anyway" because they see the benefit. The question is testing autonomy, and the correct answer is to respect the patient's refusal after ensuring they are informed and competent.

Another frequent trap involves confidentiality exceptions. Students either break confidentiality too readily (a family member asks about a diagnosis and the student discloses without patient consent) or refuse to break it when legally required (a court order mandates disclosure and the student picks "maintain confidentiality"). The key is to identify whether the scenario fits one of the recognized exceptions listed in Permenkes No. 36 of 2012. If no exception applies, confidentiality must be maintained.

On euthanasia, the trap is confusing the withdrawal of futile treatment with passive euthanasia. Both result in the patient's death after treatment is stopped, but the intent and the legal implications are completely different. If the vignette describes a brain-dead patient with no prospect of recovery and the family agrees to stop life support, this is withdrawal of futile treatment and is legally permissible. If the vignette describes a physician who stops a ventilator specifically to hasten a suffering patient's death, that is passive euthanasia and is prohibited under Indonesian law.

For informed consent, the classic distractor is a signed consent form. Students assume that because the patient signed, consent is valid. But if the patient did not understand the information (due to language barriers, cognitive impairment, or inadequate explanation), the consent is not valid regardless of the signature. The process matters more than the paper.

On abortion, the trap involves the gestational age and the two permitted exceptions. Students must know that only medical emergency and pregnancy resulting from rape are lawful grounds for induced abortion in Indonesia. Socioeconomic hardship, fetal anomaly (unless it also threatens the mother's life), or patient preference alone are not lawful grounds under current Indonesian law.

Finally, for research ethics, remember that informed consent in research is more stringent than clinical consent. The participant must know they are in a study, must understand the difference between research and standard clinical care (the therapeutic misconception), and must be able to withdraw freely. If the vignette involves a physician enrolling their own patient in a trial without clearly explaining that the experimental arm might not be superior, the question is testing for inadequate research consent.

The core competency being examined in all ethics questions is the same: can you identify the relevant principle, apply it correctly to the clinical context, and choose the answer that best balances the patient's rights, the physician's duties, and the regulatory framework?